CardioKinetix

About:

CardioKinetix is a medical device company offering the Parachutem, a catheter-based treatment for heart failure.

Website: http://www.cardiokinetix.com

Top Investors: U.S. Venture Partners, SV Health Investors, Lexington Partners, New Leaf Venture Partners, Tekla Capital Management

Description:

The Company, based in Menlo Park, has developed a novel transcatheter implant called the PARACHUTETM Ventricular Partitioning Device (PARACHUTETM). The PARACHUTETM intends to treat heart failure resulting from a heart attack or myocardial infarction in millions of patients worldwide by improving overall cardiac function.

Total Funding Amount:

$113M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2003-01-01

Contact Email:

margie(AT)cardiokinetix.com

Founders:

Serjan D. Nikolic

Number of Employees:

11-50

Last Funding Date:

2016-11-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai